The Oncosearch | Oncotarget

Targeted photodynamic therapy treatment of in vitro A375 metastatic melanoma cells Research Paper

Channay Naidoo, Cherie Ann Kruger, Heidi Abrahamse

Published Oct 22, 2019 · Vol. 10, No. 58 · pp. 6079-6095

Keywords: metastatic melanoma, nano active targeting, zinc phthalocyanine tetra-sulphonic acid, photodynamic therapy

Tumor necrosis factor related apoptosis inducing ligand (TRAIL) regulates deubiquitinase USP5 in tumor cells Research Paper

Harish Potu, Malathi Kandarpa, Luke F. Peterson, Nicholas J. Donato, Moshe Talpaz

Published Oct 8, 2019 · Vol. 10, No. 56 · pp. 5745-5754

Keywords: USP5, ubiquitin, TRAIL, DUB inhibitor, G9

Clinicopathological correlation of immune response in human cancers Research Paper

Yuexin Liu

Published Oct 8, 2019 · Vol. 10, No. 56 · pp. 5859-5870

Keywords: clinicopathological characteristics, immune response, immunogenicity, cancer

Preliminary observations on soluble programmed cell death protein-1 as a prognostic and predictive biomarker in patients with metastatic melanoma treated with patient-specific autologous vaccines Research Paper

Robert O. Dillman, Gabriel I. Nistor, Bryce T. McLelland, Candace Hsieh, Aleksandra J. Poole, Andrew N. Cornforth, Hans S. Keirstead

Published Sep 3, 2019 · Vol. 10, No. 51 · pp. 5359-5371

Keywords: programmed cell death protein -1 (PD-1), dendritic cell vaccines, metastatic melanoma

Mechanism of internalization of MDA-7/IL-24 protein and its cognate receptors following ligand-receptor docking Research Paper

Anjan K. Pradhan, Praveen Bhoopathi, Sarmistha Talukdar, Swadesh K. Das, Luni Emdad, Devanand Sarkar, Andrei I. Ivanov, Paul B. Fisher

Published Aug 20, 2019 · Vol. 10, No. 49 · pp. 5103-5117

Keywords: MDA-7/Interleukin-24, Interleukin receptor, recombinant protein

Real-world evidence to guide healthcare policies in oncology Research Perspective

Marco Donia, Steen Werner Hansen, Inge Marie Svane

Published Jul 16, 2019 · Vol. 10, No. 44 · pp. 4513-4515

Keywords: real-world evidence, real-world data, clinical trial eligibility

The landscape of novel and complementary targets for immunotherapy: an analysis of gene expression in the tumor microenvironment Research Paper

Stephen G. Gaffney, Elizabeth B. Perry, Ping-Min Chen, Andrew Greenstein, Susan M. Kaech, Jeffrey P. Townsend

Published Jul 16, 2019 · Vol. 10, No. 44 · pp. 4532-4545

Keywords: immunotherapy, tumor microenvironment, T lymphocyte, cancer genomics, RNA-seq

Tris DBA palladium is an orally available inhibitor of GNAQ mutant uveal melanoma in vivo Research Paper

Elgilda Musi, Gary K. Schwartz, Jae Hyuk Yoo, Shannon J. Odelberg, Dean Y. Li, Michael Y. Bonner, Ponniah Selvakumar, Shikha Rao, Linda C. Gilbert, Justin Elsey, Jack L. Arbiser

Published Jul 9, 2019 · Vol. 10, No. 43 · pp. 4424-4436

Keywords: melanoma, chemotherapy

Prostate-specific membrane antigen expression in hepatocellular carcinoma: potential use for prognosis and diagnostic imaging Research Paper

Yuri Tolkach, Diane Goltz, Anika Kremer, Hojjat Ahmadzadehfar, Dominik Bergheim, Markus Essler, Marnix Lam, Bart de Keizer, Hans-Peter Fischer, Glen Kristiansen

Published Jun 25, 2019 · Vol. 10, No. 41 · pp. 4149-4160

Keywords: FOLH1, hepatocellular carcinoma, PET/CT, prostate-specific membrane antigen, theranostic

GPCR-mediated PI3K pathway mutations in pediatric and adult thyroid cancer Research Paper

Avaniyapuram Kannan Murugan, Ebtesam Qasem, Hindi Al-Hindi, Ali S. Alzahrani

Published Jun 25, 2019 · Vol. 10, No. 41 · pp. 4107-4124

Keywords: thyroid cancer, mutations, PTEN, oncogene, PIK3CA

Mutations of the MAPK/TSC/mTOR pathway characterize periventricular glioblastoma with epithelioid SEGA-like morphology–morphological and therapeutic implications Research Paper

Maria-Magdalena Georgescu, Yan Li, Mohammad Zahidul Islam, Christina Notarianni, Hai Sun, Adriana Olar, Gregory N. Fuller

Published Jun 18, 2019 · Vol. 10, No. 40 · pp. 4038-4052

Keywords: epithelioid glioblastoma, SEGA-like, mTOR, MAPK, 4E-BP1

Plasma lncRNA expression profile as a prognostic tool in BRAF-mutant metastatic melanoma patients treated with BRAF inhibitor Research Paper

Tomasz Kolenda, Piotr Rutkowski, Michał Michalak, Katarzyna Kozak, Kacper Guglas, Marcel Ryś, Łukasz Galus, Sebastian Woźniak, Iwona Ługowska, Aleksandra Gos, Anna Teresiak, Andrzej Mackiewicz, Katarzyna Lamperska, Jacek Mackiewicz

Published Jun 11, 2019 · Vol. 10, No. 39 · pp. 3879-3893

Keywords: melanoma, BRAF mutation, BRAF inhibitor, lncRNA, liquid biopsy

Dissecting the role of RNA modification regulatory proteins in melanoma Research Paper

Parmanand Malvi, Biao Wang, Shreni Shah, Romi Gupta

Published Jun 4, 2019 · Vol. 10, No. 38 · pp. 3745-3759

Keywords: RNA modifications, epitranscriptome, melanoma, MAPK, BRAF mutant melanoma

Cancer-testis antigens MAGEA proteins are incorporated into extracellular vesicles released by cells Research Paper

Anneli Kuldkepp, Magda Karakai, Eve Toomsoo, Olavi Reinsalu, Reet Kurg

Published Jun 4, 2019 · Vol. 10, No. 38 · pp. 3694-3708

Keywords: cancer-testis antigens, MAGEA, extracellular vesicles, microvesicles

Regression of BRAF^V600E mutant adult glioblastoma after primary combined BRAF-MEK inhibitor targeted therapy: a report of two cases Case Report

Peter Y.M. Woo, Tai-Chung Lam, Jenny K.S. Pu, Lai-Fung Li, Roland C.Y. Leung, Jason M.K. Ho, James T.F. Zhung, Belinda Wong, Timonthy S.K. Chan, Herbert H.F. Loong, Ho-Keung Ng

Published Jun 4, 2019 · Vol. 10, No. 38 · pp. 3818-3826

Keywords: glioblastoma, BRAF^V600E mutation, targeted therapies, BRAF-MEK inhibitors

Frankincense essential oil suppresses melanoma cancer through down regulation of Bcl-2/Bax cascade signaling and ameliorates heptotoxicity via phase I and II drug metabolizing enzymes Research Paper

Faruck L. Hakkim, Hamid A. Bakshi, Shabia Khan, Mohamad Nasef, Rabia Farzand, Smitha Sam, Luay Rashan, Mohammed S. Al-Baloshi, Sidgi Syed Anwar Abdo Hasson, Ali Al Jabri, Paul A. McCarron, Murtaza M. Tambuwala

Published May 28, 2019 · Vol. 10, No. 37 · pp. 3472-3490

Keywords: melanoma, frankincense, essential oil, apoptosis, tumor remission

Melanoma patients with additional primary cancers: a single-center retrospective analysis Research Paper

Florentia Dimitriou, Joanna Mangana, Alessandra Curioni-Fontecedro, Markus Rechsteiner, Patrick Turko, Ralph P. Braun, Reinhard Dummer, Phil F. Cheng

Published May 21, 2019 · Vol. 10, No. 36 · pp. 3373-3384

Keywords: melanoma, additional primary tumors, multiple primary tumors, BRAF V600E mutation, papillary thyroid cancer

Expression dynamics of Mage family genes during self-renewal and differentiation of mouse pluripotent stem and teratocarcinoma cells Research Paper

Olga Gordeeva, Andrey Gordeev, Sergey Khaydukov

Published May 14, 2019 · Vol. 10, No. 35 · pp. 3248-3266

Keywords: melanoma antigens, cancer-testis antigens, teratocarcinoma, pluripotent stem cells, differentiation

Frankincense essential oil suppresses melanoma cancer through down regulation of Bcl-2/Bax cascade signaling and ameliorates heptotoxicity via phase I and II drug metabolizing enzymes Research Paper

Faruck L. Hakkim, Hamid A. Bakshi, Shabia Khan, Mohamad Nasef, Rabia Farzand, Smitha Sam, Luay Rashan, Al-Balushi MS, Hasson SS, Ali Al Jabri, Paul A McCarron, Murtaza M Tambuwala

Published May 3, 2019

Keywords: melanoma, frankincense, essential oil, apoptosis, tumor remission

Frankincense essential oil suppresses melanoma cancer through down regulation of Bcl-2/Bax cascade signaling and ameliorates heptotoxicity via phase I and II drug metabolizing enzymes Research Paper

Faruck L. Hakkim, Hamid A. Bakshi, Shabia Khan, Mohamad Nasef, Rabia Farzand, Smitha Sam, Luay Rashan, Al-Balushi MS, Hasson SS, Ali Al Jabri, Paul A McCarron, Murtaza M Tambuwala

Published May 3, 2019

Keywords: melanoma, frankincense, essential oil, apoptosis, tumor remission

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Targeted photodynamic therapy treatment of in vitro A375 metastatic melanoma cells Research Paper

Tumor necrosis factor related apoptosis inducing ligand (TRAIL) regulates deubiquitinase USP5 in tumor cells Research Paper

Clinicopathological correlation of immune response in human cancers Research Paper

Preliminary observations on soluble programmed cell death protein-1 as a prognostic and predictive biomarker in patients with metastatic melanoma treated with patient-specific autologous vaccines Research Paper

Mechanism of internalization of MDA-7/IL-24 protein and its cognate receptors following ligand-receptor docking Research Paper

Real-world evidence to guide healthcare policies in oncology Research Perspective

The landscape of novel and complementary targets for immunotherapy: an analysis of gene expression in the tumor microenvironment Research Paper

Tris DBA palladium is an orally available inhibitor of GNAQ mutant uveal melanoma in vivo Research Paper

Prostate-specific membrane antigen expression in hepatocellular carcinoma: potential use for prognosis and diagnostic imaging Research Paper

GPCR-mediated PI3K pathway mutations in pediatric and adult thyroid cancer Research Paper

Mutations of the MAPK/TSC/mTOR pathway characterize periventricular glioblastoma with epithelioid SEGA-like morphology–morphological and therapeutic implications Research Paper

Plasma lncRNA expression profile as a prognostic tool in BRAF-mutant metastatic melanoma patients treated with BRAF inhibitor Research Paper

Dissecting the role of RNA modification regulatory proteins in melanoma Research Paper

Cancer-testis antigens MAGEA proteins are incorporated into extracellular vesicles released by cells Research Paper

Regression of BRAF^V600E mutant adult glioblastoma after primary combined BRAF-MEK inhibitor targeted therapy: a report of two cases Case Report

Frankincense essential oil suppresses melanoma cancer through down regulation of Bcl-2/Bax cascade signaling and ameliorates heptotoxicity via phase I and II drug metabolizing enzymes Research Paper

Melanoma patients with additional primary cancers: a single-center retrospective analysis Research Paper

Expression dynamics of Mage family genes during self-renewal and differentiation of mouse pluripotent stem and teratocarcinoma cells Research Paper

Frankincense essential oil suppresses melanoma cancer through down regulation of Bcl-2/Bax cascade signaling and ameliorates heptotoxicity via phase I and II drug metabolizing enzymes Research Paper

Frankincense essential oil suppresses melanoma cancer through down regulation of Bcl-2/Bax cascade signaling and ameliorates heptotoxicity via phase I and II drug metabolizing enzymes Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Targeted photodynamic therapy treatment of in vitro A375 metastatic melanoma cells Research Paper

Tumor necrosis factor related apoptosis inducing ligand (TRAIL) regulates deubiquitinase USP5 in tumor cells Research Paper

Clinicopathological correlation of immune response in human cancers Research Paper

Preliminary observations on soluble programmed cell death protein-1 as a prognostic and predictive biomarker in patients with metastatic melanoma treated with patient-specific autologous vaccines Research Paper

Mechanism of internalization of MDA-7/IL-24 protein and its cognate receptors following ligand-receptor docking Research Paper

Real-world evidence to guide healthcare policies in oncology Research Perspective

The landscape of novel and complementary targets for immunotherapy: an analysis of gene expression in the tumor microenvironment Research Paper

Tris DBA palladium is an orally available inhibitor of GNAQ mutant uveal melanoma in vivo Research Paper

Prostate-specific membrane antigen expression in hepatocellular carcinoma: potential use for prognosis and diagnostic imaging Research Paper

GPCR-mediated PI3K pathway mutations in pediatric and adult thyroid cancer Research Paper

Mutations of the MAPK/TSC/mTOR pathway characterize periventricular glioblastoma with epithelioid SEGA-like morphology–morphological and therapeutic implications Research Paper

Plasma lncRNA expression profile as a prognostic tool in BRAF-mutant metastatic melanoma patients treated with BRAF inhibitor Research Paper

Dissecting the role of RNA modification regulatory proteins in melanoma Research Paper

Cancer-testis antigens MAGEA proteins are incorporated into extracellular vesicles released by cells Research Paper

Regression of BRAFV600E mutant adult glioblastoma after primary combined BRAF-MEK inhibitor targeted therapy: a report of two cases Case Report

Frankincense essential oil suppresses melanoma cancer through down regulation of Bcl-2/Bax cascade signaling and ameliorates heptotoxicity via phase I and II drug metabolizing enzymes Research Paper

Melanoma patients with additional primary cancers: a single-center retrospective analysis Research Paper

Expression dynamics of Mage family genes during self-renewal and differentiation of mouse pluripotent stem and teratocarcinoma cells Research Paper

Frankincense essential oil suppresses melanoma cancer through down regulation of Bcl-2/Bax cascade signaling and ameliorates heptotoxicity via phase I and II drug metabolizing enzymes Research Paper

Frankincense essential oil suppresses melanoma cancer through down regulation of Bcl-2/Bax cascade signaling and ameliorates heptotoxicity via phase I and II drug metabolizing enzymes Research Paper

Regression of BRAF^V600E mutant adult glioblastoma after primary combined BRAF-MEK inhibitor targeted therapy: a report of two cases Case Report